A gyulladásos emlorák komplex kezelése

Research output: Article

Abstract

Inflammatory beast cancer represents 2-5% of all malignant breast lesions. Its rapid progression, the rather short medical history of the disease is unique and seems to be very typical. The combined modality treatment of inflammatory breast cancer is a special challange for the medical oncologists. Preoperative chemotherapy is of great importance. After getting fair remission, surgery and radiotherapy should be delivered. With combined modality therapy the 5-year overall survival is about 50%. Knowing more pharmacogenomical details on the disease and delivering new medicaments the effectiveness of the treatment will be further enhanced.

Translated title of the contributionKomplex treatment of inflammatory breast cancer
Original languageHungarian
Pages (from-to)303-307
Number of pages5
JournalMagyar onkologia
Volume50
Issue number4
Publication statusPublished - dec. 1 2006

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'A gyulladásos emlorák komplex kezelése'. Together they form a unique fingerprint.

  • Cite this